SA
Go ProLog In
FTRE
OverviewIntelligenceChart
Next earnings: Aug 5, 2026 · Before open
Signal
Mixed1↑1↓
Price
1↓
Move↓-4.07%Selling pressure
Volume
1→
Volume→0.7× avgNormal activity
Technical
1↑
RSI↑RSI 66Momentum positive
PRICE
Prev Close
14.24
Open
13.96
Day Range13.51 – 14.05
13.51
14.05
52W Range3.97 – 18.67
3.97
18.67
66% of range
VOLUME & SIZE
Avg Volume
1.6M
FUNDAMENTALS
P/E Ratio
-2.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Performance
1D
-4.07%
5D
-12.38%
1M
+35.92%
3M
+39.53%
6M
+31.22%
YTD↓
-20.81%
1Y↑
+187.58%
Best: 1Y (+187.58%)Worst: YTD (-20.81%)
Quick Read
Trend—Insufficient MA data
Momentum
BEARISH
thin 16% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 0.9 (low) · FCF $2.09/sh
Neutral
Key MetricsTTM
Market Cap$1.29B
Revenue TTM$2.71B
Net Income TTM-$446.90M
Free Cash Flow$190.40M
Gross Margin16.0%
Net Margin-16.5%
Operating Margin-0.5%
Return on Equity-79.1%
Return on Assets-16.7%
Debt / Equity0.14
Current Ratio0.95
EPS TTM$-4.90
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong5 concern
25/100
Liquidity
0.95Concern
Leverage
0.14Strong
Coverage
-0.2xConcern
ROE
-79.1%Concern
ROIC
-0.8%Concern
Cash
$175MConcern
ANALYST COVERAGE12 analysts
HOLD
▲ +39.1%upside to target
L $14.00
Med $19.00consensus
H $25.00
Buy
542%
Hold
650%
Sell
18%
5 Buy (42%)6 Hold (50%)1 Sell (8%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
6/10
Technicals
●
RSI RangeRSI 66 — Bullish momentum
✓
Volume
●
Volume FlowNeutral
~
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 0.95 — liquidity risk
✗
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentSep 9, 2026
In 116 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendGolden Cross · 50D leads 200D by 29.8%

+17.5% vs SMA 50 · +52.5% vs SMA 200

Momentum

RSI66.0
Positive momentum, not extended
MACD+1.11
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$18.67+36.7%
Current
$13.66
EMA 50
$12.28-10.1%
EMA 200
$9.01-34.1%
52W Low
$3.97-70.9%
52-Week RangeMid-range
$3.9766th %ile$18.67
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:6
Dist days:3
Edge:+3 acc
Volume Context
Avg Vol (50D)1.4M
Recent Vol (5D)
1.1M-21%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 9 analysts
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$2.7B
$2.7B–$2.7B
—$0.51—
±4%
High8
FY2026(current)
$2.6B
$2.6B–$2.6B
▼ -4.4%$0.80▲ +56.5%
±9%
High9
FY2027
$2.7B
$2.6B–$2.8B
▲ +3.4%$1.01▲ +26.8%
±22%
High9
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryFTRE
Last 8Q
+62.8%avg beat
Beat 3 of 8 quartersMissed 5↓ Estimates falling
-143%
Q3'24
-15%
Q4'24
-50%
Q1'25
+129%
Q2'25
+217%
Q3'25
-25%
Q4'25
-44%
Q1'26
+433%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Evercore ISIOutperform
Jan 6
UPGRADE
CitigroupNeutral → Buy
Dec 11
UPGRADE
CitigroupBuy → Neutral
Dec 11
DOWNGRADE
JefferiesBuy → Hold
Sep 25
DOWNGRADE
CitigroupBuy
Dec 11
UPGRADE
Evercore ISIOutperform
Dec 1
UPGRADE
BarclaysOverweight
Nov 14
UPGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Morais Mark A.COO
$17K
Mar 16
SELL
Mcconnell Jill G.CFO
$17K
Mar 16
SELL
Parks RobertChief Accounti…
$9K
Mar 10
SELL
Parks RobertChief Accounti…
$9K
Mar 10
SELL
Morais Mark A.COO
$21K
Mar 10
SELL
Morais Mark A.COO
$21K
Mar 10
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
BlackRock, Inc.
15.2M▲
2
GOLDMAN SACHS GROUP INC
8.1M▼
3
Corvex Management LP
4.6M▲
4
Sessa Capital IM, L.P.
4.6M▲
5
STATE STREET CORP
4.1M▼
6
AQR CAPITAL MANAGEMENT LLC
3.3M▲
7
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
3.2M▼
8
DEUTSCHE BANK AG\
2.6M▲
News & Activity

FTRE News

About

No description available.

Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Leonard Scott DovePresident of Clinical Pharmacology Services
Drayton VirklerPresident & Chief Commercial Officer
Mark A. MoraisChief Operating Officer & President of Clinical Services
Peers— Health Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt Cap↓P/ERev GrwMarginELO
FTRE◀
$13.66-4.07%$1.3B—+100.1%-3621.2%1500
BBIO
$66.13-5.07%$13.0B—+12626.1%-14525.8%1500
GH
$94.92-3.79%$12.6B—+3288.2%-4239.0%1500
MDGL
$523.69-3.00%$12.1B—+43205.3%-3008.0%1500
AXSM
$227.72-1.30%$11.7B—+6554.5%-2868.8%1500
BTSG
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
ARWR
$76.67-3.79%$10.8B—+2325815.3%-19.7%1500
Sector avg—-3.12%—50.3+341864.1%-4019.2%1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance